Engineered nanomaterial captures off-target cancer drug to
prevent tissue damage

Standard chemotherapies may efficiently kill cancer
cells, but they also pose significant risks to healthy cells,
resulting in secondary illness and a diminished quality of life for
patients. To prevent the previously unavoidable damage,
researchers, led by Penn State, have developed a new class of
nanomaterials engineered to capture chemotherapy drugs before they
interact with healthy tissue.